The APEXHeart Lab (Artificial Intelligence, Preclinical & Engineering Excellence in Heart Health Laboratory) at the Harry Perkins Institute of Medical Research focuses on scalable, non-invasive technologies designed to address major unmet needs in coronary artery disease, heart failure, obesity-related cardiovascular risk and sleep-disordered breathing.
Cardiovascular disease remains a leading cause of death in Australia and globally. Many patients are diagnosed late, often after a cardiac event. Professor Dwivedi’s team is developing next-generation screening and monitoring tools that move cardiovascular care upstream. These include research from reactive treatment to proactive detection and prevention. The goal is to ensure that these solutions are accessible beyond tertiary hospitals, including primary care and remote settings.
Key research areas
- AI-powered cardiovascular imaging and predictive analysis
- Cardiometabolic disease and obesity: prevention, stratification and precision management
- Oculomics for cardiovascular risk detection and early diagnosis
- Advanced digital and remote monitoring for heart failure management
- Bioelectronic medicine and targeted neurostimulation therapies
- AI-enabled predictive modelling in cardiac electrophysiology
